INS and type 2 diabetes mellitus: Due to their strong glycemic effects, weight loss benefits, and low risk of hypoglycemia, GLP-1RAs are often recommended as the first injectable glucose-lowering therapy for patients with type T2DM, even before initiating insulin in many cases [60].